Efficacy and safety of omega-3 DHA supplementation in preterm infants: childhood follow-up of the N3RO trial.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Giving babies born 3 to 4 months prematurely the omega-3 DHA has been thought to improve their mental development. But we don’t yet know if this is indeed so. In this follow-up study, we will be able to find out the important longer-term effects at 5-years of age of extra DHA in the first months of life by assessing the children’s mental development.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $713,218.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Paediatrics and Reproductive Medicine not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

infant nutrition | neurodevelopment | omega-3 fatty acids | premature infant | respiratory morbidity